Danaher Corporation (DHR)
Pre-Market:
| Previous Close | 246.84 |
| Open | 249.54 |
| Bid | 0.00 x 900 |
| Ask | 249.39 x 800 |
| Day's Range | 247.59 - 249.73 |
| 52 Week Range | 182.09 - 259.00 |
| Volume | |
| Avg. Volume | 2,608,836 |
| Market Cap | 183.972B |
| Beta (5Y Monthly) | 0.86 |
| PE Ratio (TTM) | 45.66 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.08 (0.43%) |
| Ex-Dividend Date | Mar 27, 2024 |
| 1y Target Est | N/A |
- PR Newswire
Curiox Biosystems and Beckman Coulter Life Sciences Announce a Partnership Combining C-FREE™ Technology with DURA Innovations for Hands-Free Washed Sample Preparation for Flow Cytometry
Curiox Biosystems Co. Ltd (Curiox), a leader in the innovation of life science research technologies, and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, announce a strategic partnership to provide researchers with a one-stop solution for hands-free washed sample preparation for flow cytometry.
- PR Newswire
Danaher Reports First Quarter 2024 Results
Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended March 29, 2024. All results in this release reflect only continuing operations unless otherwise noted.
- PR Newswire
Danaher Schedules First Quarter 2024 Earnings Conference Call
Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2024 on Tuesday, April 23, 2024 beginning at 8:00 a.m. ET and lasting approximately one hour. During the call, the company will discuss its financial performance, as well as future expectations.
